Patents Assigned to Unihart Corporation
  • Anti-rhinovirus active agents
    Publication number: 20050222264
    Abstract: Glyoxal derivatives for use in the prevention and treatment of Rhinovirus infections are herein disclosed.
    Type: Application
    Filed: May 5, 2003
    Publication date: October 6, 2005
    Applicant: UNIHART CORPORATION
    Inventor: Giulio Tarro
  • Method of treating viral hepatitis by administration of liquid human ?-interferon
    Patent number: 6884411
    Abstract: Use of natural human ?-interferon for the preparation of a medicament in liquid form to be administered through peroral route at dosages comprised between 100 UI and 500 UI/day, for therapy of viral infections, in particular viral hepatitis, neoplasia and immune diseases in humans and animals.
    Type: Grant
    Filed: February 27, 1997
    Date of Patent: April 26, 2005
    Assignee: Unihart Corporation
    Inventors: Giulio Tarro, Renzo Brozzo
  • Urogenital carcinoma anti-TLP peptide antibodies, related kits and methods
    Patent number: 6664378
    Abstract: An antibody that binds to a specific urogenital carcinoma tumor liberated protein (TLP) epitope, wherein the TLP comprises GlyProProGluValGlnAsnAlaAsn, is described. Also described are kits comprising the antibody, and methods of identifying TLP, and methods for diagnosing urogenital carcinoma.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: December 16, 2003
    Assignee: Unihart Corporation
    Inventor: Giulio Tarro
  • Transdermal patch and topical compositions comprising propylnorapomorphine
    Patent number: 6592893
    Abstract: A pharmaceutical composition is characterized by: an active principle selected from one or more components of the group consisting of R(−)-propylnorapomorphine hydrochloride, S(+)-propylnorapomorphine hydrochloride, derivatives of R(−)-propylnorapomorphine hydrochloride and derivatives of S(+)-propylnorapomorphine hydrochloride, in pharmaceutically acceptable and effective doses, and further comprising components selected from the group consisting of stabilizers, solubilizers and permeation activators to facilitate the passage of the active principle through the skin. A transdermal patch that includes the pharmaceutical composition is also disclosed as well as a method of treatment for Parkinson's disease, hemicrania, sexual impotence, and psychotic disorders using the pharmaceutical composition or a transdermal patch that includes the pharmaceutical composition are described.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: July 15, 2003
    Assignee: Unihart Corporation
    Inventor: Gian Luigi Gessa
  • Urogenital carcinoma TLP peptides
    Patent number: 6222010
    Abstract: It is described a peptide consisting of a specific urogential carcinoma TLP epitope, wherein the TLP comprises the amino acid sequence GlyProProGluValGlnAsnAlaAsn. Also described are reagents to detect said urogenital TLP and pharmaceutical compositions.
    Type: Grant
    Filed: April 15, 1999
    Date of Patent: April 24, 2001
    Assignee: Unihart Corporation
    Inventor: Giulio Tarro
  • Adhesive patch for lithium controlled release
    Patent number: 6207182
    Abstract: It is described an adhesive patch for lithium or salts thereof controlled release for transcutaneous adsorption comprising: a thin, flexible, inner support having an inner side and an outer side; an adhesive which is layered onto the support inner side; at least one of lithium salts which is layered onto the support inner side; wherein the support is made of a non-repellent material for the adhesive. Preferred lithium salts are carbonate, sulphate and acetate.
    Type: Grant
    Filed: October 21, 1998
    Date of Patent: March 27, 2001
    Assignees: Istituto Farmacoterapico Italiano, Unihart Corporation
    Inventor: Armando Raimondi